当前位置:首页 - 行情中心 - 健帆生物(300529) - 财务分析 - 现金流量表

健帆生物

(300529)

  

流通市值:77.99亿  总市值:121.55亿
流通股本:5.12亿   总股本:7.99亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,113,828,219.93612,829,952.252,337,937,853.611,768,386,740.74
  收到的税费返还234,555.8-1,124,050.98946,942.18
  收到其他与经营活动有关的现金27,871,271.892,057,769.4120,926,644.4296,557,078.25
  经营活动现金流入小计1,141,934,047.62614,887,721.652,459,988,549.011,865,890,761.17
  购买商品、接受劳务支付的现金152,542,424.72100,288,085.89392,690,993.02305,564,662.82
  支付给职工以及为职工支付的现金271,729,978.46113,006,004.39529,150,844.65407,206,778.95
  支付的各项税费197,329,437.3294,818,308.66401,746,893.77314,020,246.06
  支付其他与经营活动有关的现金109,121,015.2150,883,913.85415,183,374.38265,858,918.17
  经营活动现金流出小计730,722,855.71358,996,312.791,738,772,105.821,292,650,606
  经营活动产生的现金流量净额411,211,191.91255,891,408.86721,216,443.19573,240,155.17
二、投资活动产生的现金流量:
  收回投资收到的现金1,597,050,0001,027,314,9794,534,406,869.911,919,605,241.54
  取得投资收益收到的现金5,978,577.23125,742.0953,475,879.18,757,199.6
  处置固定资产、无形资产和其他长期资产收回的现金净额3,553,428.4410,6292,861,393.122,440,528.29
  投资活动现金流入小计1,606,582,005.671,027,451,350.094,590,744,142.131,930,802,969.43
  购建固定资产、无形资产和其他长期资产支付的现金86,123,268.6542,545,502.81172,590,825.89118,273,187.59
  投资支付的现金3,374,300,0003,181,479,265.513,775,000,0003,054,950,000
  投资活动现金流出小计3,460,423,268.653,224,024,768.323,947,590,825.893,173,223,187.59
  投资活动产生的现金流量净额-1,853,841,262.98-2,196,573,418.23643,153,316.24-1,242,420,218.16
三、筹资活动产生的现金流量:
  取得借款收到的现金45,857,957.6830,481,906.94100,274,614.5778,265,413.31
  收到其他与筹资活动有关的现金-626,052.921,133,104,213.27449,965,192.89
  筹资活动现金流入小计45,857,957.6831,107,959.861,233,378,827.84528,230,606.2
  偿还债务支付的现金51,191,481.342,244,093.2263,431,621.0232,120,327.44
  分配股利、利润或偿付利息支付的现金422,786,160.91,057,149.42643,568,950.08640,672,599.99
  支付其他与筹资活动有关的现金111,923,976.55111,384,487.35889,710,113.08451,907,353.51
  筹资活动现金流出小计585,901,618.79114,685,729.971,796,710,684.181,124,700,280.94
  筹资活动产生的现金流量净额-540,043,661.11-83,577,770.11-563,331,856.34-596,469,674.74
四、汇率变动对现金及现金等价物的影响-3,893,588.93-1,821,163.03-1,722,510.72-525,067.85
五、现金及现金等价物净增加额-1,986,567,321.11-2,026,080,942.51799,315,392.37-1,266,174,805.58
  加:期初现金及现金等价物余额2,474,981,633.622,474,981,633.621,675,666,241.251,675,666,241.25
  期末现金及现金等价物余额488,414,312.51448,900,691.112,474,981,633.62409,491,435.67
补充资料:
  净利润382,988,907.47-531,671,178.89-
  资产减值准备21,568,115.01-63,877,891.55-
  固定资产和投资性房地产折旧58,636,869.73-115,092,151.34-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧58,636,869.73-115,092,151.34-
  无形资产摊销2,676,214.78-4,905,371.08-
  长期待摊费用摊销8,979,417.05-13,748,538.86-
  处置固定资产、无形资产和其他长期资产的损失-113,195.9-79,851.27-
  固定资产报废损失72,439.35-1,608,135.5-
  公允价值变动损失-18,816,274.42--11,065.14-
  财务费用24,780,525.46-53,511,826.05-
  投资损失-5,861,735.34--53,475,879.1-
  递延所得税2,044,399.19--7,052,083.45-
  其中:递延所得税资产减少-458,453.62--6,395,597.31-
    递延所得税负债增加2,502,852.81--656,486.14-
  存货的减少8,720,250.89-38,617,748.4-
  经营性应收项目的减少-15,340,007.76-10,648,124.21-
  经营性应付项目的增加-60,095,158.57--58,155,971.54-
  其他--3,644,497-
  一年内到期的可转换公司债券1,051,439,462.4---
  不涉及现金收支的投资和筹资活动金额其他项目--1,416,074.18-
  现金的期末余额488,414,312.51-2,474,981,633.62-
  减:现金的期初余额2,474,981,633.62-1,675,666,241.25-
  现金及现金等价物的净增加额-1,986,567,321.11-799,315,392.37-
公告日期2026-08-072026-04-282026-04-282025-10-30
审计意见(境内)标准无保留意见
TOP↑